uu.seUppsala University Publications
Change search
ReferencesLink to record
Permanent link

Direct link
Molecular Genetic and Epigenetic analysis of NCX2/SLC8A2 at 19q13.3 in Human Gliomas
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Neuroscience, Neurology.
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Genetics and Pathology.
Show others and affiliations
2010 (English)In: Neuropathology and Applied Neurobiology, ISSN 0305-1846, E-ISSN 1365-2990, Vol. 36, no 3, 198-210 p.Article in journal (Refereed) Published
Abstract [en]


Loss of heterozygosity (LOH) at 19q13.3 is a common genetic change in human gliomas, indicating yet unknown glial-specific tumour suppressor genes in this chromosome region. NCX2/SLC8A2 located on chromosome 19q13.32 encodes a Na(+)/Ca(2+)exchanger, which contributes to intracellular Ca(2+)homeostasis. Its expression is restricted to brain, and it is neither present in other normal tissues nor in gliomas at any significant level. The aim of this study was to investigate if NCX2 might be a tumour suppressor gene involved in glioma.


We performed a systematic analysis of NCX2 in 42 human gliomas using microsatellite analysis for evaluation of LOH at 19q, DNA sequencing and DNA methylation analysis.


Except for three known intragenic SNPs, rs12459087, rs7259674, and rs8104926, no NCX2 sequence variations were detected in any of the tumour samples. Furthermore, a CpG island in the 5' promoter region of NCX2 was unmethylated. Interestingly, the CpG sites of three gene-body CpG islands located in exon 2, intron 2-3 and exon 3 and of a 5' CpG rich area relevant to so called CpG island shore of NCX2 were methylated in all 8 glioma samples and in 3 established glioma cell lines tested. Surprisingly, NCX2 could be activated by addition of the DNA methylation inhibitor 5-aza-2'-deoxycytidine to glioma cell lines in which NCX2 was completely silent.


Results indicate that DNA methylation may play a key role in the transcriptional silencing of NCX2.

Place, publisher, year, edition, pages
2010. Vol. 36, no 3, 198-210 p.
Keyword [en]
19q13.3, DNA methylation, Glioma, Mutation, NCX2, Single nucleotide polymorphism
National Category
Medical and Health Sciences
Research subject
URN: urn:nbn:se:uu:diva-123034DOI: 10.1111/j.1365-2990.2010.01070.xISI: 000276024600003PubMedID: 20132488OAI: oai:DiVA.org:uu-123034DiVA: diva2:311659
Available from: 2010-04-22 Created: 2010-04-22 Last updated: 2013-12-18Bibliographically approved

Open Access in DiVA

No full text

Other links

Publisher's full textPubMed

Search in DiVA

By author/editor
Smits, Anja
By organisation
NeurologyDepartment of Genetics and Pathology
In the same journal
Neuropathology and Applied Neurobiology
Medical and Health Sciences

Search outside of DiVA

GoogleGoogle Scholar
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Altmetric score

Total: 265 hits
ReferencesLink to record
Permanent link

Direct link